Lamb Peter
EVP, Scientific Strategy & CSO at EXEL
- Sold, on record
- $29.5M
- Dollars the filings state
- Form 4 sales
- 25
- Latest Dec 15, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- EXELEXELIXIS, INC.EVP, Scientific Strategy & CSO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale EXELPlan not statedJun 17, 2021 2021
Sold 60,000 shares at $22.18 ($1.3M)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 13.3% of holdings ($10M position)389,467 shares left1x usual sizeFiling
- 2 Form 4 sale EXELPlan not statedJul 15, 2021 +28 days
Sold 60,000 shares at $17.47 ($1M)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 13.3% of holdings ($7.9M position)389,467 shares left1x usual sizeFiling
- 3 Form 4 sale EXELPlan not statedAug 16, 2021 +32 days
Sold 55,000 shares at $18.44 ($1M)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 12.4% of holdings ($8.2M position)389,467 shares left0.9x usual sizeFiling
- 4 Form 4 sale EXELPlan not statedSep 15, 2021 +30 days
Sold 47,500 shares at $20.46 ($972k)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 10.9% of holdings ($8.9M position)389,467 shares left0.8x usual sizeFiling
- 5 Form 4 sale EXELPlan not statedOct 15, 2021 +30 days
Sold 47,500 shares at $21.92 ($1M)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 10.4% of holdings ($10.1M position)411,240 shares left0.8x usual sizeFiling
- 6 Form 4 sale EXELPlan not statedNov 15, 2021 +31 days
Sold 47,500 shares at $18.09 ($859k)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 10.4% of holdings ($8.3M position)411,240 shares left0.8x usual sizeFiling
- 7 Form 4 sale EXELPlan not statedDec 15, 2021 +30 days
Sold 47,500 shares at $17.44 ($828k)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 11.6% of holdings ($7.2M position)363,172 shares left0.8x usual sizeFiling
- 8 Form 4 sale EXELPlan not statedDec 15, 2022 +365 days
Sold 20,000 shares at $15.88 ($318k)
Lamb Peter, EVP, Scientific Strategy & CSO
Sold 4.6% of holdings ($6.8M position)410,958 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Dec 16, 2022 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 20,000 | $318k | 4.6% | Plan not stated | SEC |
| Dec 15, 2021 | Dec 17, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 47,500 | $828k | 11.6% | Plan not stated | SEC |
| Nov 15, 2021 | Nov 17, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 47,500 | $859k | 10.4% | Plan not stated | SEC |
| Oct 15, 2021 | Oct 15, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 47,500 | $1M | 10.4% | Plan not stated | SEC |
| Sep 15, 2021 | Sep 17, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 47,500 | $972k | 10.9% | Plan not stated | SEC |
| Aug 16, 2021 | Aug 18, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 55,000 | $1M | 12.4% | Plan not stated | SEC |
| Jul 15, 2021 | Jul 16, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 60,000 | $1M | 13.3% | Plan not stated | SEC |
| Jun 17, 2021 | Jun 22, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 60,000 | $1.3M | 13.3% | Plan not stated | SEC |
| Apr 1, 2021 | Apr 2, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 60,000 | $1.4M | 13.3% | Plan not stated | SEC |
| Mar 1, 2021 | Mar 3, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 65,000 | $1.4M | 16.0% | Plan not stated | SEC |
| Feb 1, 2021 | Feb 3, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 65,000 | $1.4M | 18.7% | Plan not stated | SEC |
| Jan 4, 2021 | Jan 6, 2021 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 65,000 | $1.3M | 18.7% | Plan not stated | SEC |
| Dec 18, 2020 | Dec 22, 2020 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 65,000 | $1.3M | 18.7% | Plan not stated | SEC |
| Jun 8, 2020 | Jun 10, 2020 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 26,000 | $587k | 17.0% | Plan not stated | SEC |
| May 7, 2020 | May 8, 2020 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 50,000 | $1.3M | 28.3% | Unusual | SEC |
| Apr 6, 2020 | Apr 8, 2020 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 50,000 | $863k | 28.3% | Unusual | SEC |
| Jun 18, 2019 | Jun 19, 2019 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 217,404 | $4.5M | 65.0% | Unusual | SEC |
| Jun 13, 2019 | Jun 14, 2019 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 27,596 | $553k | 19.1% | Plan not stated | SEC |
| Mar 1, 2017 | Mar 3, 2017 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 45,000 | $999k | 37.9% | Unusual | SEC |
| Feb 1, 2017 | Feb 3, 2017 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 70,000 | $1.3M | 48.7% | Unusual | SEC |
| Jan 3, 2017 | Jan 5, 2017 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 70,000 | $1M | 48.7% | Unusual | SEC |
| Dec 1, 2016 | Dec 2, 2016 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 70,000 | $1.2M | 48.7% | Unusual | SEC |
| Nov 9, 2016 | Nov 14, 2016 | EXEL | EVP, Scientific Strategy & CSO | Form 4 sale | 70,000 | $921k | 48.7% | Unusual | SEC |
| Oct 16, 2015 | Oct 19, 2015 | EXEL | EVP, Discovery Research & CSO | Form 4 sale | 51,549 | $299k | 58.6% | Unusual | SEC |
| Oct 13, 2015 | Oct 14, 2015 | EXEL | EVP, Discovery Research & CSO | Form 4 sale | 300,876 | $1.8M | 89.2% | Unusual | SEC |